Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia - Wikidata - wikimedia - TriplyDB

Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia

Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia

http://www.wikidata.org/entity/Q36843749

about

Stem cell transplantation in chronic lymphocytic leukemia Chronic lymphocytic leukemia: a clinical review including Korean cohorts Identification of therapeutic candidates for chronic lymphocytic leukemia from a library of approved drugs Association of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cells Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia.CD38 as a prognostic marker in chronic lymphocytic leukaemia at a single New Zealand centre: patient survival in comparison to age- and sex-matched population data.Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia Identification of a 20-gene expression-based risk score as a predictor of clinical outcome in chronic lymphocytic leukemia patients.Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia.Lenalidomide and rituximab for the initial treatment of patients with chronic lymphocytic leukemia: a multicenter clinical-translational study from the chronic lymphocytic leukemia research consortium.High expression of lymphocyte-activation gene 3 (LAG3) in chronic lymphocytic leukemia cells is associated with unmutated immunoglobulin variable heavy chain region (IGHV) gene and reduced treatment-free survival.SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course ENCODE tiling array analysis identifies differentially expressed annotated and novel 5' capped RNAs in hepatitis C infected liver.Nrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemia.Clinical laboratory analysis of immunoglobulin heavy chain variable region genes for chronic lymphocytic leukemia prognosis.Large-scale analysis of DNA methylation in chronic lymphocytic leukemia Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia.Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia Analysis of CLLU1 expression levels before and after therapy in patients with chronic lymphocytic leukemia.Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia.Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL.Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia.How I treat CLL up front.Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation Predicting survival in chronic lymphocytic leukemia.Role of allogeneic transplantation in patients with chronic lymphocytic leukemia in the era of novel therapies: a review Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia.The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.Allogeneic transplantation for chronic lymphocytic leukemia White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemia.A pathobiological role of the insulin receptor in chronic lymphocytic leukemia.Cyclic nucleotide phosphodiesterase 7B mRNA: an unfavorable characteristic in chronic lymphocytic leukemia CD14(+)HLA-DR(low/-) expression: A novel prognostic factor in chronic lymphocytic leukemia.LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia.Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL.Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.Developing Molecular Signatures for Chronic Lymphocytic Leukemia.

P2860

Q24642921-D2467609-E032-47DA-9D9A-9B8B799C46F5 Q26752467-B660DE6A-AA5B-49E0-9D2E-045C3B7FB9E0 Q28533669-3D93FE70-32CE-4CDB-BF34-EB12C998F92C Q28744086-44409275-F374-411A-90D2-266AA3FAB446 Q33396594-6E89E2C0-E2F8-4665-B178-A01DDDC296AA Q33517828-BA74C583-9098-4E51-AF0E-4E704DD5D843 Q33587644-D3BFFF0A-6D27-44BF-B9D7-3C7AC80B4ABC Q33634389-32C66B56-F6DC-4839-99DC-4113FA413BFA Q33744997-D080E517-9A9C-434E-8EBA-1073F0BC49B6 Q33758834-694A4201-D25A-416B-9111-D3C55DFAA2B7 Q33774513-8E35A9AA-A646-43F0-AFAA-04D3D1FCF1C6 Q33796183-21040F0A-BC88-4865-BA77-97D6A2BCCBCD Q33813862-1434B62D-D5B1-4A8F-A5D5-270EC21A8215 Q33822016-1154E4C7-C347-4265-8D88-1B67D8C7A588 Q33832050-9E7A4A0C-5E2A-47C1-8526-9FF8AA8B32C2 Q33841975-277E966B-3EAF-435B-927E-8219177B2247 Q33856248-882F9993-AAD9-4D8A-BC50-813EBF214EFF Q33859881-8B133648-2D9A-4B6E-BF3A-C7F1C95C8213 Q33886052-12A79980-A7F6-4D58-ADA9-E0BAB05928B0 Q33910990-362991AC-87A8-477F-B377-174A57EC661D Q33965688-1B1D851A-B17D-41E8-88B0-ED88F14FFF20 Q34008593-50E001DF-57C5-4142-8894-1B30E7EF3B1A Q34008866-117E5D7B-EBA5-438B-A540-DDEC6C081477 Q34016413-8019D1D3-1029-44B0-9012-61DBD45A8798 Q34137158-BDB5E4A8-99D5-4AEC-A4D0-279FBB59E140 Q34166551-D5912478-044E-4EEE-B7D5-52559620629C Q34257190-AEF76337-2C42-45DC-8448-5CF463F464FA Q34348572-8F721CD0-9AE6-426A-8845-24E7C0886CEC Q34349298-EFAAF681-5E39-422D-99BF-5D18ACB7EDA4 Q34418874-F2B00591-4D14-428C-A802-45CB59D5C1AE Q34542102-459B108F-B99D-4FB5-A163-DF755830D19F Q34549313-7B3DBFC9-FAC5-4D24-9A7B-F6F40ADC6D84 Q34750656-12578F05-E873-40FF-AAA1-9B19D0AD1CFA Q34917625-C65FE5E9-5E2F-40E1-B071-DFA1DBF30E94 Q35036721-7BE48DE9-A035-4D1F-901F-D1C7A50B6030 Q35042003-CC6A2E85-9916-40B3-9084-3ECBAB24D0E7 Q35143479-40DCACC8-4A20-4F36-B0FA-B4D7B68E08BD Q35188629-FD891903-F0AD-4EEF-A6FD-1B20A8237C3B Q35220403-CB2A4F4C-E91D-4840-9F1C-510FC48FF6E4 Q35653850-C1A461FD-6DEE-43BA-83A5-7367BE65C664

P2860

Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia

http://www.wikidata.org/entity/Q36843749

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Relative value of ZAP-70, CD38 ...... n chronic lymphocytic leukemia

@en

type

label

Relative value of ZAP-70, CD38 ...... n chronic lymphocytic leukemia

@en

prefLabel

Relative value of ZAP-70, CD38 ...... n chronic lymphocytic leukemia

@en

P1433

Q36843749-45C4E443-A234-4C49-8F38-0ED8B92367C7

P1476

Q36843749-6F20EA05-40A0-4C90-848D-CB64A3EA9A8B

P2093

Q36843749-068F8392-D61F-4F3D-AE1F-489CE919CABA

Q36843749-0D35EC11-C18B-4EDB-B57C-2A16B9C69699

Q36843749-202D69BC-C074-4215-904F-16F19969211C

Q36843749-43F9DA68-5818-4526-B30D-40EC501ACA41

Q36843749-4D7F26BA-484E-437E-B721-E614AE8AE8B7

Q36843749-6EA606E1-4DAA-4449-8E3B-F62D6EF7A58B

Q36843749-8EBC5D33-A79E-482D-898A-A31A41C9C127

Q36843749-9458F1AB-B0B7-420D-B35A-77E1FF73197E

Q36843749-A921D1D9-4970-4DF8-BB01-1930903534C7

Q36843749-EDF25B1A-07E3-4D22-A805-842123951611

P2860

Q36843749-04113CAF-C204-46CC-8DFB-1E8B8EC8CB59

Q36843749-0489C5F2-3C2E-47EB-BF3C-4DA2BC60A9B6

Q36843749-06EFB68C-D58A-4301-B04D-AE607E0CB336

Q36843749-197700A5-4CFE-4D3A-BF66-C01DA73B9B40

Q36843749-1AB1EC3C-30D3-41C2-9A79-7E680EDB0DA5

Q36843749-236CA1C3-2C70-423F-814A-A6FE7E9BC65D

Q36843749-2B27ED60-53E9-41BC-A02B-7166A58F099E

Q36843749-2E3AA843-4823-4216-ACD6-784D790A3787

Q36843749-2F7D9F7C-4D3A-4475-97DE-D9C3D5A1FC93

Q36843749-3B07C2E8-29CB-438E-8378-315D04188D87

P304

Q36843749-1F3A8924-BC94-4C7A-8380-6E61A4BB2941

P31

Q36843749-8DE23E99-20E7-4D5E-81CB-D4ADEB9965F9

P356

Q36843749-8C14D78E-30C8-45B2-8552-EC92A79B3102

P407

Q36843749-C10DDA81-8AD2-4C71-BD35-B519DD2BABE3

P433

Q36843749-5DB10619-D593-4A12-BD37-0036CEE8DCA4

P478

Q36843749-638A86FF-332C-4472-887D-74CFAA030E0E

P50

Q36843749-B1A59519-9B78-4424-8738-40A9FD8F8AC9

Q36843749-BE82036C-FC78-4E8D-98FC-5FE4E4C6BED1

Q36843749-E37DF093-7E99-47B8-B22C-26E03284EBCF

P577

Q36843749-AD711393-24FC-48AD-9636-A59CEBEA8A7E

P5875

Q36843749-34F367B8-A22F-4DCF-915C-E01A3A3BA5DC

P698

Q36843749-103B0685-9F52-43C7-ABAF-69FCC34AC8BB

P921

Q36843749-52C9603B-34E3-415F-949B-64790474B8E2

Q36843749-62AE8214-77F6-43F6-AAAB-9BE5320EC5F6

P932

Q36843749-3DB3920E-C639-4FC6-8C6D-CABA03F994E5

P356

BLOOD-2007-05-092882

P1433

P1476

Relative value of ZAP-70, CD38 ...... n chronic lymphocytic leukemia

@en

P2093

Andrew W Greaves

http://www.w3.org/2001/XMLSchema#string

Donna S Neuberg

http://www.w3.org/2001/XMLSchema#string

Feng He

http://www.w3.org/2001/XMLSchema#string

Jennifer R Brown

http://www.w3.org/2001/XMLSchema#string

John G Gribben

http://www.w3.org/2001/XMLSchema#string

Kanti R Rai

http://www.w3.org/2001/XMLSchema#string

Laura Z Rassenti

http://www.w3.org/2001/XMLSchema#string

Michael R Grever

http://www.w3.org/2001/XMLSchema#string

Neil E Kay

http://www.w3.org/2001/XMLSchema#string

Sonia Jain

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.

CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.

B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimens.

CD38 as a prognostic marker in CLL.

Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia.

P304

1923-1930

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2007-05-092882

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

William G Wierda

Michael J. Keating

P577

2008-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5277938

http://www.w3.org/2001/XMLSchema#string

P698

18577710

http://www.w3.org/2001/XMLSchema#string

P921

P932

2518894

http://www.w3.org/2001/XMLSchema#string